Literature DB >> 18695986

Analysis of the genes coding for the BRCA1-interacting proteins, RAP80 and Abraxas (CCDC98), in high-risk, non-BRCA1/2, multiethnic breast cancer cases.

David J Novak1, Nelly Sabbaghian, Philippe Maillet, Pierre O Chappuis, William D Foulkes, Marc Tischkowitz.   

Abstract

Background Around half of familial breast cancer cases are caused by germ-line mutations in genes which are critically involved in the maintenance of genome stability. Mutations in related genes functioning in DNA repair may account for currently unattributed cases. Two such genes, RAP80 and Abraxas, have recently been identified to be in a complex with BRCA1, and are required for the localization of BRCA1 to DNA damage foci. Methods RAP80 and Abraxas variants were screened for in a cohort of 95 high risk, non-BRCA1/2 breast cancer cases of varying ethnicity: those of Ashkenazi Jewish (n = 35), mixed Canadian (n = 34) and Swiss descent (n = 26). Results We have identified four missense variants, four silent SNPs, three SNPs in the UTRs and seven intronic variants in RAP80. Two of the previously reported RAP80 variants were further investigated. In Abraxas, we have identified two missense, nine intronic and two variants in the 3' UTR. Conclusions Overall, it seems unlikely that moderate to highly penetrant alleles of either RAP80 or Abraxas, confer a significantly high relative risk of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18695986     DOI: 10.1007/s10549-008-0134-y

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  11 in total

1.  Long-range massively parallel mate pair sequencing detects distinct mutations and similar patterns of structural mutability in two breast cancer cell lines.

Authors:  Oliver A Hampton; Maxim Koriabine; Christopher A Miller; Cristian Coarfa; Jian Li; Petra Den Hollander; Caroline Schoenherr; Lucia Carbone; Mikhail Nefedov; Boudewijn F H Ten Hallers; Adrian V Lee; Pieter J De Jong; Aleksandar Milosavljevic
Journal:  Cancer Genet       Date:  2011-08

2.  RAP80 is critical in maintaining genomic stability and suppressing tumor development.

Authors:  Zhengyu Yin; Daniel Menendez; Michael A Resnick; John E French; Kyathanahalli S Janardhan; Anton M Jetten
Journal:  Cancer Res       Date:  2012-08-15       Impact factor: 12.701

3.  Connecting the Dots: Interplay between Ubiquitylation and SUMOylation at DNA Double-Strand Breaks.

Authors:  Jiang-Bo Tang; Roger A Greenberg
Journal:  Genes Cancer       Date:  2010-07

4.  Breast cancer-associated Abraxas mutation disrupts nuclear localization and DNA damage response functions.

Authors:  Szilvia Solyom; Bernadette Aressy; Katri Pylkäs; Jeffrey Patterson-Fortin; Jaana M Hartikainen; Anne Kallioniemi; Saila Kauppila; Jenni Nikkilä; Veli-Matti Kosma; Arto Mannermaa; Roger A Greenberg; Robert Winqvist
Journal:  Sci Transl Med       Date:  2012-02-22       Impact factor: 17.956

5.  Familial breast cancer screening reveals an alteration in the RAP80 UIM domain that impairs DNA damage response function.

Authors:  J Nikkilä; K A Coleman; D Morrissey; K Pylkäs; H Erkko; T E Messick; S-M Karppinen; A Amelina; R Winqvist; R A Greenberg
Journal:  Oncogene       Date:  2009-03-23       Impact factor: 9.867

Review 6.  Coiled-Coil Domain-Containing (CCDC) Proteins: Functional Roles in General and Male Reproductive Physiology.

Authors:  Patra Priyadarshini Priyanka; Suresh Yenugu
Journal:  Reprod Sci       Date:  2021-05-03       Impact factor: 3.060

7.  Expression of the BRCA1 complex member BRE predicts disease free survival in breast cancer.

Authors:  Sylvie M Noordermeer; Marloes Wennemers; Saskia M Bergevoet; Adrian van der Heijden; Evelyn Tönnissen; Fred C G J Sweep; Joop H Jansen; Paul N Span; Bert A van der Reijden
Journal:  Breast Cancer Res Treat       Date:  2012-06-16       Impact factor: 4.872

8.  Mutation screening of the RNF8, UBC13 and MMS2 genes in Northern Finnish breast cancer families.

Authors:  Mikko Vuorela; Katri Pylkäs; Robert Winqvist
Journal:  BMC Med Genet       Date:  2011-07-21       Impact factor: 2.103

9.  Characterization of the novel tumor-suppressor gene CCDC67 in papillary thyroid carcinoma.

Authors:  De Tao Yin; Jianhui Xu; Mengyuan Lei; Hongqiang Li; Yongfei Wang; Zhen Liu; Yubing Zhou; Mingzhao Xing
Journal:  Oncotarget       Date:  2016-02-02

10.  ABRAXAS (FAM175A) and Breast Cancer Susceptibility: No Evidence of Association in the Breast Cancer Family Registry.

Authors:  Anne-Laure Renault; Fabienne Lesueur; Yan Coulombe; Stéphane Gobeil; Penny Soucy; Yosr Hamdi; Sylvie Desjardins; Florence Le Calvez-Kelm; Maxime Vallée; Catherine Voegele; John L Hopper; Irene L Andrulis; Melissa C Southey; Esther M John; Jean-Yves Masson; Sean V Tavtigian; Jacques Simard
Journal:  PLoS One       Date:  2016-06-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.